The RELIEF™ Ureteral Stent Randomized Controlled Trial
Launched by UNIVERSITY OF CALIFORNIA, SAN DIEGO · Dec 2, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The RELIEF™ Ureteral Stent Randomized Controlled Trial is studying how well a special tube called the RELIEF® Ureteral Stent works for people with kidney stones. This trial will check if there is any backward flow of urine from the bladder into the ureter after placing the stent. Researchers will use imaging (like X-rays or CT scans) to better understand how the stent is functioning in the first 48 hours after placement.
To be eligible for this trial, participants need to be 18 years or older and have confirmed kidney stones or blockages in the ureter. They should be able to provide consent and be willing to follow the study guidelines. However, certain individuals, like those with specific urinary issues or infections, may not be able to participate. If chosen, participants can expect to have the stent placed and be monitored closely for any issues related to its function. It's important to know that this trial is not yet recruiting, so it may take some time before anyone can enroll.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Has capacity to consent
- • Stated willingness to comply with all study procedures and availability for the duration of the study
- • Persons, 18 years of age or older
- • Male or female subjects with confirmed ureteral and/or renal stones or strictures documented via abdomen X-ray KUB (kidney ureter bladder) or CT (computed tomography)
- Exclusion Criteria:
- • Distal ureteral obstruction where suture portion of stent may be placed
- • Urinary reflux (assessed by pre-stent cystogram)
- • Pregnancy or lactation
- • Patients requiring bilateral surgical stone management procedure
- • Infected stones
- • Patients where 24cm or 26cm stent lengths are not suitable
- • Ureteral structure in distal third of ureter
- • Intraoperative exclusion: based on urologist's discretion, if trauma has been induced to the distal ureter due to ureteroscopy maneuvers, exclude these patients
About University Of California, San Diego
The University of California, San Diego (UCSD) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust focus on translational medicine, UCSD leverages its interdisciplinary approach to explore groundbreaking therapies and interventions across a wide range of medical fields. The university's state-of-the-art facilities and collaboration with top-tier faculty and researchers ensure a comprehensive and ethical framework for conducting clinical trials, ultimately aiming to enhance patient outcomes and contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Seth K Bechis, MD
Principal Investigator
University of California, San Diego
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported